Works matching IS 0195668X AND DT 2016 AND VI 37 AND IP 17

Results: 20

Electron microscopy reveals morphosis of multi-layered mitochondria in the myocardium of a patient with mitochondrial cardiomyopathy.

Published in:

European Heart Journal, 2016, v. 37, n. 17, p. 1372, doi. 10.1093/eurheartj/ehv764

By:

Masataka Ikeda;
Yasuhiro Sezutsu;
Takafumi Sakamoto;
Tomomi Ide

Publication type:

Article

Replacing statins with PCSK9-inhibitors and delaying treatment until 18 years of age in patients with familial hypercholesterolemia is not a good idea.

Published in:

European Heart Journal, 2016, v. 37, n. 17, p. 1357, doi. 10.1093/eurheartj/ehw098

By:

Langslet, Gisle

Publication type:

Article

Northwestern Cardiovascular Young Investigators' Forum, 2015 Winners.

Published in:: European Heart Journal, 2016, v. 37, n. 17, p. 1350
Publication type:: Article

The annual Northwestern Cardiovascular Young Investigators' Forum in Chicago.

Published in:

European Heart Journal, 2016, v. 37, n. 17, p. 1348

By:

Tofield, A.

Publication type:

Article

Professor Ulrich Laufs MD.

Published in:

European Heart Journal, 2016, v. 37, n. 17, p. 1347

By:

Tofield, Andros

Publication type:

Article

Cardiac perforation as a rare complication of acupuncture.

Published in:

European Heart Journal, 2016, v. 37, n. 17, p. 1383, doi. 10.1093/eurheartj/ehv171

By:

Wigger, Olivier;
Stortecky, Stefan;
Most, Henriette;
Englberger, Lars

Publication type:

Article

Huge left ventricle cardiac fibroma in an adult patient.

Published in:

European Heart Journal, 2016, v. 37, n. 17, p. 1369, doi. 10.1093/eurheartj/ehw043

By:

Dongxu Li;
Shuhua Luo;
YaboWang;
Qi An

Publication type:

Article

The biology of PCSK9 inhibition: some unanswered questions.

Published in:

European Heart Journal, 2016, v. 37, n. 17, p. 1345

By:

Lambert, Gilles;
Diotel, Nicolas;
Tavori, Hagai

Publication type:

Article

Patients with familial hypercholesterolaemia are characterized by presence of cardiovascular disease at the time of death.

Published in:

European Heart Journal, 2016, v. 37, n. 17, p. 1398, doi. 10.1093/eurheartj/ehv602

By:

Krogh, Henriette Walaas;
Mundal, Liv;
Holven, Kirsten B.;
Retterstol, Kjetil

Publication type:

Article

Familial hypercholesterolaemia: a common disease.

Published in:

European Heart Journal, 2016, v. 37, n. 17, p. 1395, doi. 10.1093/eurheartj/ehw130

By:

Ray, Kausik K.;
Hovingh, G. Kees

Publication type:

Article

Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217.

Published in:

European Heart Journal, 2016, v. 37, n. 17, p. 1384, doi. 10.1093/eurheartj/ehw028

By:

Benn, Marianne;
Watts, Gerald F.;
Tybjoerg-Hansen, Anne;
Nordestgaard, Borge G.

Publication type:

Article

Lower might be better - It matters how you get there, and in whom.

Published in:

European Heart Journal, 2016, v. 37, n. 17, p. 1380, doi. 10.1093/eurheartj/ehw102

By:

Robinson, Jennifer G.

Publication type:

Article

Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents.

Published in:

European Heart Journal, 2016, v. 37, n. 17, p. 1373, doi. 10.1093/eurheartj/ehw046

By:

Ridker, Paul M.;
Mora, Samia;
Rose, Lynda

Publication type:

Article

Monoclonal antibodies targeting PCSK9 and the search for prolonged duration of effect.

Published in:

European Heart Journal, 2016, v. 37, n. 17, p. 1370, doi. 10.1093/eurheartj/ehw023

By:

Ridker, Paul M.

Publication type:

Article

Safety and efficacy of LY3015014, a monoclonal antibody to proprotein convertase subtilisin/ kexin type 9 (PCSK9): a randomized, placebo-controlled Phase 2 study.

Published in:

European Heart Journal, 2016, v. 37, n. 17, p. 1360, doi. 10.1093/eurheartj/ehv707

By:

Kastelein, John J. P.;
Nissen, Steven E.;
Rader, Daniel J.;
Hovingh, G. Kees;
Ming-Dauh Wang;
Tong Shen;
Krueger, Kathryn A.

Publication type:

Article

Nabil G. Seidah PhD.

Published in:

European Heart Journal, 2016, v. 37, n. 17, p. 1345

By:

Tofield, A.

Publication type:

Article

Initiation of PCSK9 inhibition in patients with heterozygous familial hypercholesterolemia entering adulthood: a new design for living with a high-risk condition?

Published in:

European Heart Journal, 2016, v. 37, n. 17, p. 1353, doi. 10.1093/eurheartj/ehw010

By:

Vuorio, Alpo;
Watts, Gerald F.;
Kovanen, Petri T.

Publication type:

Article

What have we learned so far from the biology of PCSK9?

Published in:

European Heart Journal, 2016, v. 37, n. 17, p. 1343

By:

Seidah, Nabil G.

Publication type:

Article

The PCSK9 story.

Published in:

European Heart Journal, 2016, v. 37, n. 17, p. 1341, doi. 10.1093/eurheartj/ehw089

By:

Abifadel, Marianne;
Boileau, Catherine

Publication type:

Article

LDL-cholesterol targets: perspectives for the use of PCSK9 inhibitors.

Published in:

European Heart Journal, 2016, v. 37, n. 17, p. 1337, doi. 10.1093/eurheartj/ehw150

By:

Lüscher, Thomas F.

Publication type:

Article